Direxion Daily S&P Biotech Bull 3X ETF
LABU
13 hedge funds and large institutions have $12.9M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 6 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
0.22% less ownership
Funds ownership: 0.44% → 0.21% (-0.22%)
8% less capital invested
Capital invested by funds: $14.1M → $12.9M (-$1.16M)
28% less funds holding
Funds holding: 18 → 13 (-5)
37% less call options, than puts
Call options by funds: $13M | Put options by funds: $20.8M
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Cutler Group
San Francisco,
California
|
+$1.13M |
| 2 |
HJMC
Hellman Jordan Management Company
Quincy,
Massachusetts
|
+$939K |
| 3 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
+$848K |
| 4 |
Morgan Stanley
New York
|
+$401K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$274K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$2.39M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$343K |
| 3 |
CT
CMT Trading
Chicago,
Illinois
|
-$232K |
| 4 |
Jane Street
New York
|
-$222K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$107K |
LABU Hedge Fund Activity: Q4 2016 in Review
13 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2016, worth a combined $12.9M — down 8.3% from $14.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of LABU and 1 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 8 added.
The largest buyer was Cutler Group, adding an estimated $1.13M. The largest seller was Virtu Financial, exiting entirely with an estimated $2.39M sold.
- 13 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2016, down from 18 in Q3 2016.
- Funds reported $12.9M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2016, down 8.3% quarter-over-quarter.
- 1 fund opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2016 and 6 closed out, a net change of -5 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2016 was Cutler Group, an estimated $1.13M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2016 was Virtu Financial, an estimated $2.39M sold.
Based on aggregated 13F filings for Q4 2016.